Convergence Investment Partners’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Convergence Investment Partners's HALO Position: Q2 2026 in Review
Convergence Investment Partners sold out of Halozyme (HALO) in Q2 2026, closing a stake of 37,599 shares — an estimated $2.43M sold.
Convergence Investment Partners first reported a position in HALO in Q3 2015 and held it in 11 quarters. The position peaked at $3.38M in Q3 2015. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Convergence Investment Partners reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
- Convergence Investment Partners sold 37,599 Halozyme shares in Q2 2026, an estimated $2.43M.
- Convergence Investment Partners first reported a position in Halozyme in Q3 2015 and held it in 11 quarters.
- Convergence Investment Partners's Halozyme position peaked at $3.38M in Q3 2015.
- 673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Convergence Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.